| Literature DB >> 35043141 |
Jeanne M McCaffery1, Kathleen A Jablonski2, Qing Pan2, Arne Astrup3, Malene Revsbech Christiansen4, Dolores Corella5, Lauren M L Corso1, Jose C Florez6,7,8, Paul W Franks9,10, Christopher Gardner11, Torben Hansen4, Tuomas O Kilpeläinen4, William C Knowler12, Jaana Lindström13, Wim H M Saris14, Thorkild I A Sørensen15, Jaakko Tuomilehto13,16,17, Matti Uusitupa18, Rena R Wing19, Tanya Agurs-Collins20.
Abstract
Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) associated with waist circumference (WC) and waist-to-hip ratio (WHR) adjusted for BMI (WCadjBMI and WHRadjBMI), but it remains unclear whether these SNPs relate to change in WCadjBMI or WHRadjBMI with lifestyle intervention for weight loss. We hypothesized that polygenic scores (PS) comprised of 59 SNPs previously associated with central adiposity would predict less of a reduction in WCadjBMI or WHRadjBMI at 8-10 weeks in two lifestyle intervention trials, NUGENOB and DiOGenes, and at 1 year in five lifestyle intervention trials, Look AHEAD, Diabetes Prevention Program, Diabetes Prevention Study, DIETFITS, and PREDIMED-Plus. One-SD higher PS related to a smaller 1-year change in WCadjBMI in the lifestyle intervention arms at year 1 and thus predicted poorer response (β = 0.007; SE = 0.003; P = 0.03) among White participants overall and in White men (β = 0.01; SE = 0.004; P = 0.01). At average weight loss, this amounted to 0.20-0.28 cm per SD. No significant findings emerged in White women or African American men for the 8-10-week outcomes or for WHRadjBMI. Findings were heterogeneous in African American women. These results indicate that polygenic risk estimated from these 59 SNPs relates to change in WCadjBMI with lifestyle intervention, but the effects are small and not of sufficient magnitude to be clinically significant.Entities:
Mesh:
Year: 2022 PMID: 35043141 PMCID: PMC9114721 DOI: 10.2337/db21-0741
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.337